×
S&P 500   3,883.81 (+1.01%)
DOW   31,276.53 (+0.77%)
QQQ   291.46 (+0.92%)
AAPL   144.15 (+0.86%)
MSFT   266.64 (+0.16%)
META   171.07 (+0.77%)
GOOGL   2,324.32 (+1.43%)
AMZN   114.84 (+0.45%)
TSLA   707.87 (+1.82%)
NVDA   154.94 (+2.41%)
NIO   22.21 (+6.63%)
BABA   122.47 (+2.81%)
AMD   77.31 (+2.60%)
MU   59.04 (+2.91%)
T   21.20 (+0.52%)
GE   62.29 (+1.17%)
F   11.54 (+4.34%)
DIS   96.98 (+0.94%)
AMC   12.88 (+2.47%)
PFE   53.19 (+0.83%)
PYPL   73.88 (+0.87%)
NFLX   187.71 (+1.98%)
S&P 500   3,883.81 (+1.01%)
DOW   31,276.53 (+0.77%)
QQQ   291.46 (+0.92%)
AAPL   144.15 (+0.86%)
MSFT   266.64 (+0.16%)
META   171.07 (+0.77%)
GOOGL   2,324.32 (+1.43%)
AMZN   114.84 (+0.45%)
TSLA   707.87 (+1.82%)
NVDA   154.94 (+2.41%)
NIO   22.21 (+6.63%)
BABA   122.47 (+2.81%)
AMD   77.31 (+2.60%)
MU   59.04 (+2.91%)
T   21.20 (+0.52%)
GE   62.29 (+1.17%)
F   11.54 (+4.34%)
DIS   96.98 (+0.94%)
AMC   12.88 (+2.47%)
PFE   53.19 (+0.83%)
PYPL   73.88 (+0.87%)
NFLX   187.71 (+1.98%)
S&P 500   3,883.81 (+1.01%)
DOW   31,276.53 (+0.77%)
QQQ   291.46 (+0.92%)
AAPL   144.15 (+0.86%)
MSFT   266.64 (+0.16%)
META   171.07 (+0.77%)
GOOGL   2,324.32 (+1.43%)
AMZN   114.84 (+0.45%)
TSLA   707.87 (+1.82%)
NVDA   154.94 (+2.41%)
NIO   22.21 (+6.63%)
BABA   122.47 (+2.81%)
AMD   77.31 (+2.60%)
MU   59.04 (+2.91%)
T   21.20 (+0.52%)
GE   62.29 (+1.17%)
F   11.54 (+4.34%)
DIS   96.98 (+0.94%)
AMC   12.88 (+2.47%)
PFE   53.19 (+0.83%)
PYPL   73.88 (+0.87%)
NFLX   187.71 (+1.98%)
S&P 500   3,883.81 (+1.01%)
DOW   31,276.53 (+0.77%)
QQQ   291.46 (+0.92%)
AAPL   144.15 (+0.86%)
MSFT   266.64 (+0.16%)
META   171.07 (+0.77%)
GOOGL   2,324.32 (+1.43%)
AMZN   114.84 (+0.45%)
TSLA   707.87 (+1.82%)
NVDA   154.94 (+2.41%)
NIO   22.21 (+6.63%)
BABA   122.47 (+2.81%)
AMD   77.31 (+2.60%)
MU   59.04 (+2.91%)
T   21.20 (+0.52%)
GE   62.29 (+1.17%)
F   11.54 (+4.34%)
DIS   96.98 (+0.94%)
AMC   12.88 (+2.47%)
PFE   53.19 (+0.83%)
PYPL   73.88 (+0.87%)
NFLX   187.71 (+1.98%)
LON:VEC

Vectura Group Share Forecast, Price & News

GBX 164.80
0.00 (0.00%)
(As of 10/18/2021)
Add
Compare
Today's Range
164.63
165
50-Day Range
164.80
164.80
52-Week Range
100
176
Volume
203,761 shs
Average Volume
3.37 million shs
Market Capitalization
£1.01 billion
P/E Ratio
8.20
Dividend Yield
23.06%
Price Target
GBX 150

Vectura Group MarketRank™ Forecast

Analyst Rating
Hold
2.00 Rating Score
Upside/​Downside
9.0% Downside
GBX 150 Price Target
Short Interest
N/A
Dividend Strength
Weak
Based on Four Factors
Sustainability
N/A
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank

MarketRank is calculated as 30% analysis score, 20% valuation score, 10% short interest score, 10% dividend score, 10% sustainability score, 10% news and social score, and 10% insider trading score.

0.94 out of 5 stars

30 days | 90 days | 365 days | Advanced Chart

Receive VEC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Vectura Group and its competitors with MarketBeat's FREE daily newsletter.

Vectura Group logo

About Vectura Group (LON:VEC) Stock

Vectura Group plc engages in the design, development, and supply of pharmaceutical products for the treatment of airways-related diseases worldwide. The company's in-market products include Seebri, Breezhaler and Neohaler, a DPI device and bronchodilator; AirFluSal Forspiro for the treatment of asthma and chronic obstructive pulmonary disease (COPD); Breelib for the treatment of pulmonary arterial hypertension; Relvar Ellipta/Breo Ellipta that is used in treating asthma and COPD; and Incruse Ellipta, Anoro Ellipta, and Trelegy Ellipta for the treatment of COPD. It is also developing VR315 (US) for the treatment of asthma and COPD.In addition, the company offers dry powder inhalers, pressurized metered dose inhalers, and nebulized devices. Vectura Group plc was founded in 1997 and is headquartered in Chippenham, the United Kingdom.

VEC Stock News Headlines

Philip Morris (PM) Secures More than 74% Stake in Vectura
Block Vectura takeover, Philip Morris investors urged
Norges Bank - Form 8.3 - Vectura Group Plc
Form 8.3 - VECTURA GROUP PLC - 20210827
Philip Morris Acquires 22.6% Stake In Vectura
Form 8.3 - Form-8.3 - VECTURA GROUP PLC - 20210816
See More Headlines

Industry, Sector and Symbol

Industry
Drug Manufacturers - Major
Sub-Industry
N/A
Sector
Medical
CIK
N/A
Fax
N/A
Employees
9,200
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
GBX 150
High Stock Price Forecast
GBX 150
Low Stock Price Forecast
GBX 150
Forecasted Upside/Downside
-9.0%
Consensus Rating
Hold
Rating Score (0-4)
2
Research Coverage
2 Analysts

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£190.60 million
Cash Flow
GBX 13.20 per share
Book Value
GBX 91.70 per share

Miscellaneous

Free Float
N/A
Market Cap
£1.01 billion
Optionable
Optionable
Beta
N/A














Vectura Group Frequently Asked Questions

Should I buy or sell Vectura Group stock right now?

2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Vectura Group in the last year. There are currently 2 hold ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" Vectura Group stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in VEC, but not buy additional shares or sell existing shares.
View analyst ratings for Vectura Group
or view top-rated stocks.

What is Vectura Group's stock price forecast for 2022?

2 brokers have issued twelve-month price objectives for Vectura Group's stock. Their VEC stock forecasts range from GBX 150 to GBX 150. On average, they anticipate Vectura Group's share price to reach GBX 150 in the next twelve months. This suggests that the stock has a possible downside of 9.0%.
View analysts' price targets for Vectura Group
or view top-rated stocks among Wall Street analysts.

How has Vectura Group's stock price performed in 2022?

Vectura Group's stock was trading at GBX 164.80 at the beginning of 2022. Since then, VEC shares have increased by 0.0% and is now trading at GBX 164.80.
View the best growth stocks for 2022 here
.

Is Vectura Group a good dividend stock?

Vectura Group(LON:VEC) pays an annual dividend of GBX 38 per share and currently has a dividend yield of 23.06%. VEC has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The dividend payout ratio of Vectura Group is 189.05%. Payout ratios above 75% are not desirable because they may not be sustainable.
View Vectura Group's dividend history.

Who are Vectura Group's key executives?

Vectura Group's management team includes the following people:
  • Mr. William Downie, CEO & Exec. Director (Age 54, Pay $538.92k)
  • Mr. Paul Andrew Fry, CFO & Exec. Director (Age 54, Pay $807k)
  • Mr. Anthony Fitzpatrick, Exec. VP of Operations
  • Dr. Geraldine Venthoye, Chief Scientific Officer & Exec. VP of Product Devel.
  • Elizabeth Knowles, VP of Investor Relations
  • Mr. John Murphy, Gen. Counsel & Company Sec. (Age 68)
  • David Ginivan, VP of Corp. Communications
  • Ms. Christina Olsen, Exec. VP of Corp. Strategy & Communications
  • Ms. Joanne Hombal, Exec. VP of HR (Age 47)
  • Mr. Roger Heerman, Exec. VP of Commercial & Bus. Devel. (Age 48)

What other stocks do shareholders of Vectura Group own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Vectura Group investors own include Hikma Pharmaceuticals (HIK), SEB (SKP), BTG (BTG), iRobot (IRBT), Sinclair Pharma (SPH), Sirius Minerals (SXX), Coats Group (COA), Griffin Mining (GFM), HSBC (HSBA) and Inmarsat (ISAT).

What is Vectura Group's stock symbol?

Vectura Group trades on the London Stock Exchange (LON) under the ticker symbol "VEC."

How do I buy shares of Vectura Group?

Shares of VEC and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is Vectura Group's stock price today?

One share of VEC stock can currently be purchased for approximately GBX 164.80.

How much money does Vectura Group make?

Vectura Group (LON:VEC) has a market capitalization of £1.01 billion and generates £190.60 million in revenue each year.

How many employees does Vectura Group have?

Vectura Group employs 9,200 workers across the globe.

How can I contact Vectura Group?

Vectura Group's mailing address is One Prospect West, CHIPPENHAM, SN14 6FH, United Kingdom. The official website for Vectura Group is www.vectura.com. The company can be reached via phone at +44-1249-667700.

This page (LON:VEC) was last updated on 7/7/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.